Neuronasal-Team
Thomas I. Bradshaw, BA, MBA – CEO
President /CEO
- Contract drug development company serving most of the major biotech companies in US.
- Organized the purchase of the company in 2003 including arranging financing with private equity. Led turnaround and profitable growth of company. Sold to SV Life Sciences and Bain in 2007.
- Many lessons learned from clients’ decisions.
Since then:
- Buckeye Pharmaceuticals – now in clinical development for topical diseases – co-founder and currently chairman
- Great Lakes Pharmaceuticals, former chairman and co-founder – just completed pivotal clinical trials for catheter lock (IP from MD Anderson, Case Western)
- Devirex Pharmaceuticals – herpes prevention drug on the market in the EU – co-founder
- Zin Medical Europe – remote patient monitoring (IP from NASA prime contractor and Cleveland Clinic)
Michael Kaufman,
Vice President, Business Development & Commercialization.
Douglas A. Greene MD,
Head of Research
Joe Hulihan MD,
Consulting Chief Medical Officer